Ambassador Eric Goosby, the U.S. global AIDS coordinator, said that a recent $75 million pledge from the Bill & Melinda Gates Foundation, Chevron and Johnson & Johnson could help “eliminate new HIV-infected children by 2015 and keep mothers alive,” McClatchy/News & Observer reports.
“We are entering a new era in HIV prevention. PEPFAR promoted a ‘combination prevention’ strategy from the beginning. But the tools were limited. Scientific advances could give individuals the ability to determine the prevention intervention that works best for them. Preliminary mathematical models suggest that combining a full range of prevention interventions is additive â€“ and could drive the epidemic down to a manageable level so that when a vaccine is available, it could mop up what remains,” former U.S. Global AIDS Coordinator Ambassador Mark Dybul writes in a Huffington Post opinion piece.
Citing PEPFAR, the Millennium Challenge Corporation, and the President’s Malaria Initiative as pieces of the “remarkable success story” of U.S. foreign aid over the past decade, former Congress member and Ambassador to Tanzania Mark Green writes in a post on the Modernizing Foreign Assistance Network’s “ModernizeAid” blog, “While our budget…
In statement released Thursday, USAID Administrator Rajiv Shah said, “I congratulate the Partners PrEP and CDC TDF2 teams on their study findings demonstrating that PrEP (pre-exposure prophylaxis) â€“ and HIV medication when taken orally, once a day â€“ is highly effective in preventing HIV in heterosexual men and women. â€¦…
Swaziland’s King Mswati III on Friday called on men in the kingdom to get circumcised to help reduce their risk of contracting HIV, Agence France-Presse reports. “Urging his nation to ‘take care of your lives â€“ stay away from activities that could give you the disease,’ the king struck a very different note from his pronouncement to parliament a decade ago that HIV-positive people should be ‘branded and sterilized,'” the news agency writes.
In her latest piece on the New York Times’ “Opinionator” blog, author and journalist Tina Rosenberg argues that the terms of Gilead’s recent agreement with the Medicines Patent Pool is “confirmation of a dangerous new trend: middle-income countries as a target market for drug makers.” “The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China â€“ middle-income countries, all â€“ as if they or their governments could pay hundreds or even thousands of dollars a year each for AIDS drugs. This low-volume high-profit strategy might make business sense. But in terms of the war against AIDS, it means surrender,” she writes.
“The neglected tropical diseases (NTDs) produce a devastating level of chronic disability in sub-Saharan Africa, with some estimates suggesting that the NTD disease burden exceeds tuberculosis and is one-half that of malaria,” Julie Noblick and Richard Skolnick of George Washington University and Peter Hotez of the Sabin Vaccine Institute write in a PLoS Neglected Tropical Diseases editorial. With noted relationships between the prevalence of NTDs and HIV, the diseases “demand a public health response from the established global HIV/AIDS community, in parallel with efforts to scale up NTD control,” they argue.
With recent scientific advancements in HIV prevention “transforming the way we think about AIDS,” PEPFAR’s “task is to translate new science into policy to inform programs,” U.S. GlobalÂ AIDS Coordinator Ambassador Eric Goosby writes in a post on the State Department’s “DipNote” blog. “To do this, we are working with the…
With the new knowledge that providing antiretroviral (ARV) treatment to people living with HIV “contribut[es] to a sharp slowdown in the spread of the virus,” “scaling up treatment now may prove to be the least expensive option if we want to bring this deadly pandemic, which still infects 1.8 million people every year, under control,” Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria writes in the Guardian’s “Poverty Matters Blog.”
“Uganda has sometimes been considered a success story in fighting HIV and has been a darling of international donors,” including the U.S., which “has poured over $1 billion into the country for AIDS programs. But throughout Uganda there are people â€¦ who are passed over, denied treatment, or simply invisible to the country’s HIV prevention and treatment programs. Groups such as gay men, migrants, drug users, sex workers, and people with disabilities, as well as prisoners, are commonly left out,” Kathryn Todrys, a researcher with Human Rights Watch writes in GlobalPost’s “Global Pulse” blog.